X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with Sterling Biotech - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs STERLING BIOTECH - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

STERLING BIOTECH 
   Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD STERLING BIOTECH MERCK LTD/
STERLING BIOTECH
 
P/E (TTM) x 33.3 -1.9 - View Chart
P/BV x 3.7 0.1 4,973.7% View Chart
Dividend Yield % 0.8 0.0 -  

Financials

 MERCK LTD   STERLING BIOTECH
EQUITY SHARE DATA
    MERCK LTD
Dec-16
STERLING BIOTECH
Dec-13
MERCK LTD/
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs1,06011 10,095.2%   
Low Rs6233 18,323.5%   
Sales per share (Unadj.) Rs632.426.8 2,359.2%  
Earnings per share (Unadj.) Rs45.7-15.0 -305.7%  
Cash flow per share (Unadj.) Rs62.3-5.5 -1,140.7%  
Dividends per share (Unadj.) Rs11.000-  
Dividend yield (eoy) %1.30-  
Book value per share (Unadj.) Rs388.854.9 708.5%  
Shares outstanding (eoy) m16.60267.87 6.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.30.3 513.2%   
Avg P/E ratio x18.4-0.5 -3,961.3%  
P/CF ratio (eoy) x13.5-1.3 -1,061.4%  
Price / Book Value ratio x2.20.1 1,709.0%  
Dividend payout %24.10-   
Avg Mkt Cap Rs m13,9691,862 750.3%   
No. of employees `0001.61.4 116.9%   
Total wages/salary Rs m1,487547 271.9%   
Avg. sales/employee Rs Th6,631.95,303.3 125.1%   
Avg. wages/employee Rs Th939.2403.8 232.6%   
Avg. net profit/employee Rs Th479.4-2,959.0 -16.2%   
INCOME DATA
Net Sales Rs m10,4987,181 146.2%  
Other income Rs m24243 569.0%   
Total revenues Rs m10,7417,223 148.7%   
Gross profit Rs m1,135947 119.9%  
Depreciation Rs m2762,543 10.8%   
Interest Rs m04,377 0.0%   
Profit before tax Rs m1,102-5,931 -18.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m343-1,924 -17.8%   
Profit after tax Rs m759-4,007 -18.9%  
Gross profit margin %10.813.2 82.0%  
Effective tax rate %31.132.4 96.0%   
Net profit margin %7.2-55.8 -13.0%  
BALANCE SHEET DATA
Current assets Rs m6,41014,335 44.7%   
Current liabilities Rs m8,82849,809 17.7%   
Net working cap to sales %-23.0-494.0 4.7%  
Current ratio x0.70.3 252.3%  
Inventory Days Days58403 14.3%  
Debtors Days Days38171 22.5%  
Net fixed assets Rs m1,40655,432 2.5%   
Share capital Rs m166268 62.0%   
"Free" reserves Rs m6,28613,935 45.1%   
Net worth Rs m6,45514,701 43.9%   
Long term debt Rs m09,478 0.0%   
Total assets Rs m8,82873,988 11.9%  
Interest coverage xNM-0.4-  
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x1.20.1 1,225.3%   
Return on assets %8.60.5 1,716.2%  
Return on equity %11.8-27.3 -43.1%  
Return on capital %17.1-6.4 -265.7%  
Exports to sales %8.325.9 32.0%   
Imports to sales %21.00.2 12,385.8%   
Exports (fob) Rs m8691,860 46.7%   
Imports (cif) Rs m2,20912 18,108.2%   
Fx inflow Rs m9591,860 51.6%   
Fx outflow Rs m2,61225 10,494.2%   
Net fx Rs m-1,6531,835 -90.1%   
CASH FLOW
From Operations Rs m1,0701,719 62.3%  
From Investments Rs m-750-3,148 23.8%  
From Financial Activity Rs m-1501,426 -10.5%  
Net Cashflow Rs m171-3 -5,026.5%  

Share Holding

Indian Promoters % 0.0 33.9 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 18.2 0.0 -  
FIIs % 1.0 9.9 10.1%  
ADR/GDR % 0.0 16.9 -  
Free float % 29.1 39.3 74.0%  
Shareholders   28,591 21,482 133.1%  
Pledged promoter(s) holding % 0.0 55.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   VENUS REMEDIES  ORCHID PHARMA LTD  GSK PHARMA  J.B.CHEMICALS  SHASUN PHARMA  

Compare MERCK LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Share Markets Open Flat; Metal Stocks Witness Selling(09:30 am)

Asian stock markets are lower today as Chinese and Hong Kong shares fall. The Shanghai Composite is off 0.23% while the Hang Seng is down 0.49%. The Nikkei 225 is trading down by 0.55%.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Mutual Funds Clearly Tell Us That There is a Bubble in the Stock Market(Vivek Kaul's Diary)

Jan 11, 2018

The maximum amount of money ever has come into equity mutual funds during the current financial year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

'Smart Money' Enters Bitcoin. Will You?(Smart Contrarian)

Jan 17, 2018

As institutional money enters bitcoin, the gains over the last year could just be the tip of the iceberg.

Increasing Divergence Between Bond Yields and Earnings Yield(Chart Of The Day)

Jan 11, 2018

Over the past couple of months, bond yields have risen, but earning yields have fallen, increasing divergence.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Jan 24, 2018 09:31 AM

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MERCK LTD - ALKEM LABORATORIES COMPARISON

COMPARE MERCK LTD WITH

MARKET STATS